Detection of Multidrug-Resistant -From ESBLs to Carbapenemases

Overview

Journal Antibiotics (Basel)

Specialty Pharmacology

Date 2021 Sep 28

PMID 34572722

Citations 27

Authors

Janina Noster

Philipp Thelen

Axel Hamprecht

Affiliations

Soon will be listed here.

Abstract

Multidrug-resistant (MDRE) are an emerging threat to global health, leading to rising health care costs, morbidity and mortality. Multidrug-resistance is commonly caused by different β-lactamases (e.g., ESBLs and carbapenemases), sometimes in combination with other resistance mechanisms (e.g., porin loss, efflux). The continuous spread of MDRE among patients in hospital settings and the healthy population require adjustments in healthcare management and routine diagnostics. Rapid and reliable detection of MDRE infections as well as gastrointestinal colonization is key to guide therapy and infection control measures. However, proper implementation of these strategies requires diagnostic methods with short time-to-result, high sensitivity and specificity. Therefore, research on new techniques and improvement of already established protocols is inevitable. In this review, current methods for detection of MDRE are summarized with focus on culture based and molecular techniques, which are useful for the clinical microbiology laboratory.

Citing Articles

Carbapenem-resistant Enterobacterales (CRE) colonisation as a predictor for subsequent CRE infection: A retrospective surveillance study.

Tubb C, Tubb M, Hooijer J, Chomba R, Nel J S Afr J Infect Dis. 2025; 40(1):687.

PMID: 39968233 PMC: 11830835. DOI: 10.4102/sajid.v40i1.687.

Prevalence and clinical significance of the genotypic carriage among ESBL phenotype-negative and clinical isolates in bacteremia: a study in a Malaysian tertiary center.

Lau C, Neoh H, Periyasamy P, Tg Abu Bakar Sidik T, Tan T, Ramli R Front Cell Infect Microbiol. 2024; 14:1429830.

PMID: 39512590 PMC: 11540778. DOI: 10.3389/fcimb.2024.1429830.

Increasing Fluroquinolone Susceptibility and Genetic Diversity of ESBL-Producing from the Lower Respiratory Tract during the COVID-19 Pandemic.

Hrovat K, Seme K, Ambrozic Avgustin J Antibiotics (Basel). 2024; 13(9).

PMID: 39334972 PMC: 11428890. DOI: 10.3390/antibiotics13090797.

Current Strategy for Targeting Metallo-β-Lactamase with Metal-Ion-Binding Inhibitors.

Ortega-Balleza J, Vazquez-Jimenez L, Ortiz-Perez E, Avalos-Navarro G, Paz-Gonzalez A, Lara-Ramirez E Molecules. 2024; 29(16).

PMID: 39203022 PMC: 11356879. DOI: 10.3390/molecules29163944.

Reliability of a Screening Method Using Antibiotic Disks to Detect Carbapenemases in Glucose-Nonfermenting Gram-Negative Microorganisms From Clinical Samples of a Regional Hospital in Southeastern Spain.

Hernandez-Chico I, Rodriguez-Guerrero E, Exposito-Ruiz M, Navarro-Mari J, Gutierrez-Fernandez J J Clin Lab Anal. 2024; 38(8):e25036.

PMID: 38619303 PMC: 11073814. DOI: 10.1002/jcla.25036.

References

Logan L, Weinstein R . The Epidemiology of Carbapenem-Resistant Enterobacteriaceae: The Impact and Evolution of a Global Menace. J Infect Dis. 2017; 215(suppl_1):S28-S36. PMC: 5853342. DOI: 10.1093/infdis/jiw282. View

Girlich D, Poirel L, Nordmann P . Value of the modified Hodge test for detection of emerging carbapenemases in Enterobacteriaceae. J Clin Microbiol. 2011; 50(2):477-9. PMC: 3264163. DOI: 10.1128/JCM.05247-11. View

Girlich D, Bernabeu S, Fortineau N, Dortet L, Naas T . Evaluation of the CRE and ESBL ELITe MGB® kits for the accurate detection of carbapenemase- or CTX-M-producing bacteria. Diagn Microbiol Infect Dis. 2018; 92(1):1-7. DOI: 10.1016/j.diagmicrobio.2018.02.001. View

Pasteran F, Tijet N, Melano R, Corso A . Simplified Protocol for Carba NP Test for Enhanced Detection of Carbapenemase Producers Directly from Bacterial Cultures. J Clin Microbiol. 2015; 53(12):3908-11. PMC: 4652111. DOI: 10.1128/JCM.02032-15. View

Gallah S, Decre D, Genel N, Arlet G . The β-Lacta test for direct detection of extended-spectrum-β-lactamase-producing Enterobacteriaceae in urine. J Clin Microbiol. 2014; 52(10):3792-4. PMC: 4187766. DOI: 10.1128/JCM.01629-14. View

Anantharajah A, Tossens B, Olive N, Kabamba-Mukadi B, Rodriguez-Villalobos H, Verroken A . Performance Evaluation of the MBT STAR-Carba IVD Assay for the Detection of Carbapenemases With MALDI-TOF MS. Front Microbiol. 2019; 10:1413. PMC: 6596351. DOI: 10.3389/fmicb.2019.01413. View

Hopkins K, Meunier D, Naas T, Volland H, Woodford N . Evaluation of the NG-Test CARBA 5 multiplex immunochromatographic assay for the detection of KPC, OXA-48-like, NDM, VIM and IMP carbapenemases. J Antimicrob Chemother. 2018; 73(12):3523-3526. DOI: 10.1093/jac/dky342. View

Sattler J, Brunke A, Hamprecht A . Evaluation of CARBA PAcE, a novel rapid test for detection of carbapenemase-producing . J Med Microbiol. 2020; 70(2). PMC: 8131015. DOI: 10.1099/jmm.0.001290. View

Verroken A, Despas N, Rodriguez-Villalobos H, Laterre P . The impact of a rapid molecular identification test on positive blood cultures from critically ill with bacteremia: A pre-post intervention study. PLoS One. 2019; 14(9):e0223122. PMC: 6762135. DOI: 10.1371/journal.pone.0223122. View

10.

Yoon E, Lee E, Hwang D, Lee H, Baek J, Jeong S . Direct detection of intact Klebsiella pneumoniae carbapenemases produced by Enterobacterales using MALDI-TOF MS. J Antimicrob Chemother. 2020; 75(5):1174-1181. DOI: 10.1093/jac/dkaa007. View

11.

Meier M, Hamprecht A . Systematic Comparison of Four Methods for Detection of Carbapenemase-Producing Directly from Blood Cultures. J Clin Microbiol. 2019; 57(11). PMC: 6813004. DOI: 10.1128/JCM.00709-19. View

12.

Espinar M, Rocha R, Ribeiro M, Rodrigues A, Pina-Vaz C . Extended-spectrum β-lactamases of Escherichia coli and Klebsiella pneumoniae screened by the VITEK 2 system. J Med Microbiol. 2011; 60(Pt 6):756-760. DOI: 10.1099/jmm.0.024075-0. View

13.

Doi Y, Potoski B, Adams-Haduch J, Sidjabat H, Pasculle A, Paterson D . Simple disk-based method for detection of Klebsiella pneumoniae carbapenemase-type beta-lactamase by use of a boronic acid compound. J Clin Microbiol. 2008; 46(12):4083-6. PMC: 2593264. DOI: 10.1128/JCM.01408-08. View

14.

Jonas D, Reuter S, Klassen S, Weber S, Buck M, Giani T . Evaluation of the BD Phoenix CPO detect panel for prediction of Ambler class carbapenemases. Sci Rep. 2021; 11(1):13150. PMC: 8222379. DOI: 10.1038/s41598-021-92336-3. View

15.

Burrack-Lange S, Personne Y, Huber M, Winkler E, Weile J, Knabbe C . Multicenter assessment of the rapid Unyvero Blood Culture molecular assay. J Med Microbiol. 2018; 67(9):1294-1301. PMC: 6230722. DOI: 10.1099/jmm.0.000804. View

16.

Huang T, Bogaerts P, Berhin C, Guisset A, Glupczynski Y . Evaluation of Brilliance ESBL agar, a novel chromogenic medium for detection of extended-spectrum-beta- lactamase-producing Enterobacteriaceae. J Clin Microbiol. 2010; 48(6):2091-6. PMC: 2884496. DOI: 10.1128/JCM.02342-09. View

17.

Dallenne C, da Costa A, Decre D, Favier C, Arlet G . Development of a set of multiplex PCR assays for the detection of genes encoding important beta-lactamases in Enterobacteriaceae. J Antimicrob Chemother. 2010; 65(3):490-5. DOI: 10.1093/jac/dkp498. View

18.

Mota R, Pinto M, Palmeira J, Goncalves D, Ferreira H . Multidrug-resistant bacteria as intestinal colonizers and evolution of intestinal colonization in healthy university students in Portugal. Access Microbiol. 2021; 3(1):acmi000182. PMC: 8115976. DOI: 10.1099/acmi.0.000182. View

19.

Huang T, Poirel L, Bogaerts P, Berhin C, Nordmann P, Glupczynski Y . Temocillin and piperacillin/tazobactam resistance by disc diffusion as antimicrobial surrogate markers for the detection of carbapenemase-producing Enterobacteriaceae in geographical areas with a high prevalence of OXA-48 producers. J Antimicrob Chemother. 2013; 69(2):445-50. DOI: 10.1093/jac/dkt367. View

20.

Florio W, Baldeschi L, Rizzato C, Tavanti A, Ghelardi E, Lupetti A . Detection of Antibiotic-Resistance by MALDI-TOF Mass Spectrometry: An Expanding Area. Front Cell Infect Microbiol. 2020; 10:572909. PMC: 7686347. DOI: 10.3389/fcimb.2020.572909. View